CATALAYER NEWS
Replimune to resubmit twice-rejected drug for approval after FDA shakeup
Source: CNBC Top · 2026-05-29
Replimune was among the drugmakers that had criticized the FDA for what they called inconsistent guidance around trials and approvals.
MORE FROM CNBC TOP
Postal Service proposes requiring states to provide mail-in ballot voter lists
2026-05-29
The ins and outs of short squeezes — and how to avoid getting burned by them
2026-05-29
As SpaceX IPO nears, traders think it's a near-certainty Musk becomes the first trillionaire
2026-05-29
Dell shocks Wall Street with booming AI server sales. Where analysts see it headed next
2026-05-29
Jim Cramer says Nvidia is a clear winner from Dell's monster quarter
2026-05-29
RELATED ON CATALAYER
Related Topics
Biotech & FDA NewsRELATED MARKETS
Prediction Markets